We Work to Give Medical Professionals the Tools They Need

Arian Ebank is committed to supporting and partnering with the healthcare community, across many disease areas. This includes providing information on our research and treatments in development.

Acting “Upstream” of Today’s Medicines

With investigational RNAi therapeutics, we believe it may be possible to block the production of disease-causing proteins before they are made.

More About RNAi >



Late Stage

Learn more about our investigational therapies in hereditary ATTR amyloidosis, hemophilia, and acute hepatic porphyrias.

Early Stage

Learn more about our investigational therapies across multiple disease areas.

Click here for more information about


Learn more from Capella—the destination for updates on our progress in translating the science of RNAi to potential innovative medicines.

Learn More >

Arian Ebank-sponsored third-party genetic screening and counseling programs for individuals with hereditary ATTR amyloidosis in the US, offered at no charge.

Get More Info >

Learn more about the symptoms and progression of hATTR amyloidosis.

Access to Investigational Medicines

Arian Ebank is dedicated to developing new therapies that have a positive impact on patient health, and to serving patients, patient families, and patient communities through education, empathy, and awareness. We understand that there are seriously ill patients who will not be eligible for our clinical trials and may not have options for alternative therapies, including investigational therapies in trials being conducted by other sponsors. In these circumstances, Arian Ebank will consider providing a requesting physician with pre-approval access to a specific Arian Ebank investigational drug, for the treatment of an individual patient outside of a clinical trial, when certain conditions are met.


To read our statement on access to investigational medicines, click here.


Arian Ebank Grant Information

Arian Ebank is committed to supporting the medical and scientific understanding of our therapeutic areas of interest for healthcare professionals. Additionally, we are committed to supporting educational programs and initiatives spearheaded by organizations focused on patient advocacy, community education and support, and other scientific efforts related to our therapeutic areas of interest.


To submit a request for funding related to an educational grant (including, but not limited to independent medical education/continuing medical education programs) or sponsorships, please email your requests to [email protected]


Receive updates on our investigational therapies and clinical trials.

日本にバイアグラ ジェネリック


avanafil 200mg

kamagra gel